Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f73e5a0f-536f-4a0d-9ef0-9c66d2a3c3c8&Preview=1 -
Date
10/30/2008 -
Company Name
Alnara Pharmaceuticals Inc -
Mailing Address
800 Boylston Street Boston, MA 02199 -
Company Description
Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases. -
Website
http://www.alnara.com
-
Transaction Type
Venture Equity -
Transaction Amount
$20,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds from the financing will be used to accelerate the development of non-systemic protein therapeutics. -
M&A Terms
-
Venture Investor
Frazier Healthcare Ventures -
Venture Investor
Third Rock Ventures -
Venture Investor
Bessemer Venture Partners
